These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 9187529)
21. Deprenyl in Parkinson's disease. Korczyn AD; Nisipeanu P Ann Neurol; 1996 Aug; 40(2):268-9. PubMed ID: 8773617 [No Abstract] [Full Text] [Related]
22. Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc Analysis. Giladi N; Asgharnejad M; Bauer L; Grieger F; Boroojerdi B J Parkinsons Dis; 2016 Apr; 6(2):401-11. PubMed ID: 27061066 [TBL] [Abstract][Full Text] [Related]
23. Deprenyl and levodopa and Parkinson's disease progression. Fowler JS; Fazzini E; Volkow ND Ann Neurol; 1996 Aug; 40(2):267-8. PubMed ID: 8773616 [No Abstract] [Full Text] [Related]
24. Current status of selegiline as a neuroprotective agent in Parkinson's disease. Olanow CW; Mytilineou C; Tatton W Mov Disord; 1998; 13 Suppl 1():55-8. PubMed ID: 9613720 [No Abstract] [Full Text] [Related]
25. Deprenyl in the treatment of Parkinson's disease: clinical effects and speculations on mechanism of action. Olanow CW J Neural Transm Suppl; 1996; 48():75-84. PubMed ID: 8988463 [TBL] [Abstract][Full Text] [Related]
26. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors. Chen JJ; Fernandez HH Drugs Aging; 2007; 24(8):663-80. PubMed ID: 17702535 [TBL] [Abstract][Full Text] [Related]
28. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Stopping selegeline may lead to problems for patients. Anderson KE; Girdwood AC; Wilson JA BMJ; 1996 Mar; 312(7032):702; author reply 704-5. PubMed ID: 8597745 [No Abstract] [Full Text] [Related]
29. Selegiline and excess mortality. Oakes D Clin Neuropharmacol; 1997 Dec; 20(6):542. PubMed ID: 9403228 [No Abstract] [Full Text] [Related]
31. [Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages]. Pagonabarraga J; Rodríguez-Oroz MC Rev Neurol; 2013 Jan; 56(1):25-34. PubMed ID: 23250679 [TBL] [Abstract][Full Text] [Related]
33. Strategies in the treatment of early Parkinson's disease. Rinne UK Acta Neurol Scand Suppl; 1993; 146():50-3. PubMed ID: 8101417 [TBL] [Abstract][Full Text] [Related]
34. Rasagiline as a therapy for Parkinson's disease (PD). Hermanowicz N Am J Geriatr Pharmacother; 2007 Jun; 5(2):174-5; author reply 175-6. PubMed ID: 17719520 [No Abstract] [Full Text] [Related]
35. Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study. Ben-Shlomo Y; Lees A; Neurology; 2001 Jul; 57(2):369; author reply 369-70. PubMed ID: 11480425 [No Abstract] [Full Text] [Related]
36. Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study. Van Gerpen JA; Ahlskog JE Neurology; 2001 Jul; 57(2):368-9; author reply 369-70. PubMed ID: 11468339 [No Abstract] [Full Text] [Related]
37. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors. Henchcliffe C; Schumacher HC; Burgut FT Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338 [TBL] [Abstract][Full Text] [Related]
38. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used. Gerlach M; Riederer P; Vogt H BMJ; 1996 Mar; 312(7032):704; author reply 704-5. PubMed ID: 8597750 [No Abstract] [Full Text] [Related]
39. Recent developments in the pharmacological treatment of Parkinson's disease. Tuite P; Riss J Expert Opin Investig Drugs; 2003 Aug; 12(8):1335-52. PubMed ID: 12882620 [TBL] [Abstract][Full Text] [Related]
40. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom. BMJ; 1993 Aug; 307(6902):469-72. PubMed ID: 8400928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]